Showing results (491-500 of 19,970) with videos related to
Sort By:
Pageof 1,997
International Journal of Cardiology|November 19, 2018
Prolonged QRS duration as a predictor of right ventricular dysfunction after balloon pulmonary angioplastyRyotaro Asano, Takeshi Ogo, Keiko Ohta-Ogo, et al.International Journal of Cardiology|February 17, 2019
An RCT of brief cognitive therapy versus treatment as usual in patients with non-cardiac chest painRoger Mulder, Julie Zarifeh, Joseph Boden, et al.International Journal of Cardiology|February 19, 2019
Management of idiopathic recurrent pericarditis during pregnancyAntonio Brucato, Nikki Pluymaekers, Enrico Tombetti, et al.International Journal of Cardiology|February 13, 2021
Sacubitril-valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fractionClaudio Passino, Paolo Sciarrone, Giuseppe Vergaro, et al.International Journal of Cardiology|February 14, 2021
Effectiveness and safety of infliximab in cardiac SarcoidosisA L M Bakker, H Mathijssen, J Azzahhafi, et al.International Journal of Cardiology|February 14, 2021
Clinical management of young competitive athletes with premature ventricular beats: A prospective cohort studyAlex Di Florio, Chiara Fusi, Francesca Anselmi, et al.International Journal of Cardiology|February 15, 2021
Combining sodium-glucose cotransporter 2 inhibitors and angiotensin receptor-neprilysin inhibitors in heart failure patients with reduced ejection fraction and diabetes mellitus: A multi-institutional studyFu-Chih Hsiao, Chia-Pin Lin, Ying-Chang Tung, et al.International Journal of Cardiology|February 16, 2021
Prognostic value of longitudinal strain and ejection fraction in Friedreich's ataxiaL Legrand, C Heuze, A Diallo, et al.International Journal of Cardiology|February 23, 2021
Transcatheter aortic valve replacement performed with selective telemetry monitoring: A prospective studyMariama Akodad, Eissa Aldhaheri, Gregory Marin, et al.International Journal of Cardiology|February 8, 2021
Empagliflozin increases plasma levels of campesterol, a marker of cholesterol absorption, in patients with type 2 diabetes: Association with a slight increase in high-density lipoprotein cholesterolTeruo Jojima, Shintaro Sakurai, Sho Wakamatsu, et al.Pageof 1,997